SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
----------------
SCHEDULE 13G
(Rule 13d-102)
INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT
TO RULES 13d-1(b) AND (c) AND AMENDMENTS THERETO FILED
PURSUANT TO 13D-2(b)
(Amendment No. )1
---
IMMUNE NETWORK RESEARCH LTD.
- --------------------------------------------------------------------
(Name of Issuer)
COMMON STOCK WITHOUT PAR VALUE
- --------------------------------------------------------------------
(Title of Class of Securities)
452925100
- --------------------------------------------------------------------
(CUSIP Number)
December 29,1999
- --------------------------------------------------------------------
(DATE OF EVENT WHICH REQUIRES FILING OF THIS STATEMENT)
Check the appropriate box to designate the rule pursuant to which this
Schedule is filed
[ ] Rule 13d 1(b)
[ ] Rule 13d 1(c)
[X] Rule 13d 1(d)
1 The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter the
disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
<PAGE>
CUSIP No 452925100 13G Page of Pages
------------------ ----- ------
- -------------------------------------------------------------------------------
1. Names of Reporting Persons I.R.S. Identification Nos. of Above Persons
(entities only)
ALLEN I. BAIN
- -------------------------------------------------------------------------------
2. Check the Appropriate Box if a Member of a Group* (a) [ ]
(b) [ ]
NOT APPLICABLE
- -------------------------------------------------------------------------------
3. SEC Use Only
- -------------------------------------------------------------------------------
4. Citizenship or Place of Organization
CANADA
- -------------------------------------------------------------------------------
Number of Shares 5. Sole Voting Power 3,695,555
-------------------------------------------------------------
Beneficially
Owned 6. Shared Voting Power N/A
-------------------------------------------------------------
by Each
Reporting 7. Sole Dispositive Power 3,695,555
-------------------------------------------------------------
Person
With 8. Shared Dispositive Power N/A
- -------------------------------------------------------------------------------
9. Aggregate Amount Beneficially Owned by Each Reporting Person
3,695,555
- -------------------------------------------------------------------------------
10. Check if the Aggregate Amount in Row (9) Excludes Certain Shares*
[ ]
- -------------------------------------------------------------------------------
11. Percent of Class Represented by Amount in Row 9
12.99%
- -------------------------------------------------------------------------------
12. Type of Reporting Person*
IN
- -------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
<PAGE>
Item 1
Item 1(a) Name of Issuer:
IMMUNE NETWORK RESEARCH LTD.
- -------------------------------------------------------------------------------
Item 1(b) Address of Issuer's Principal Executive Offices:
3540 Wesbrook Mall, Vancouver BC, V6S 2L2
- -------------------------------------------------------------------------------
Item 2(a) Name of Person Filing:
ALLEN I. BAIN
- -------------------------------------------------------------------------------
Item 2(b) Address of Principal Business Office or, if none, Residence:
3650 Wesbrook Mall, Vancouver BC, V6S 2L2
- -------------------------------------------------------------------------------
Item 2(c) Citizenship:
Canadian
- -------------------------------------------------------------------------------
Item 2(d) Title of Class of Securities:
Common Stock Without Par Value
- -------------------------------------------------------------------------------
Item 2(e) CUSIP Number:
452925100
- -------------------------------------------------------------------------------
Item 3. If this statement is filed pursuant to Rules 13d-1(b), or 13d-2(b) or
(c), check whether the person filing is a:
(a) [ ] Broker or Dealer registered under Section 15 of the Act.
(b) [ ] Bank as defined in Section 3(a)(6) of the Act.
(c) [ ] Insurance Company as defined in Section 3(a)(19) of the Act.
(d) [ ] Investment Company registered under Section 8 of the Investment
Company Act
(e) [ ] Investment Adviser registered under Section 203 of the Investment
Advisers Act of 1940
(e) [ ] Investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E);
-----------------------
(f) [ ] Employee Benefit Plan, Pension Fund which is subject to the
provisions of the Employee Retirement Income Security Act of
1974 or Endowment Fund; see 13d-1(b)(1)(ii)(F),
(g) [ ] Parent Holding Company, in accordance with Rule
13d-1(b)(1)(ii)(G);see Item 7
(h) [ ] Group, in accordance with Rule 13d-1(b)(1)(ii)(H).
Item 4. Ownership
If the percent of the class owned, as of December 31 of the year covered
by the statement, or as of the last day of any month described in Rule 13d-1(b)
(2), if applicable, exceeds five percent, provide the following information as
of that date and identify those shares which there is a right to acquire.
(a) Amount Beneficially Owned:
3,695,555
- -------------------------------------------------------------------------------
(b) Percent of class
12.99%
- -------------------------------------------------------------------------------
(c) Number of shares as to which such person has:
(i) Sole power to vote or to direct the vote 3,695,555
------------------------
(ii) Shared power to vote or to direct the vote N/A
----------------------
(iii) Sole power to dispose or to direct the disposition of 3,695,555
-----------
<PAGE>
(iv) Shared power to dispose or to direct the disposition of N/A
---------
Instruction.-For computations regarding securities which represent
a right to acquire an underlying security see Rule 13d-3(d)(1).
Item 5. Ownership of Five Percent or Less of a Class.
If this statement is being filed to report the fact that as of the date
hereof the reporting person has ceased to be the beneficial owner of more than
five percent of the class of securities, check the following [ ].
Instruction. Dissolution of a group requires a response to this item.
Item 6. Ownership of More than Five Percent on Behalf of Another Person
If any other person is known to have the right to receive or the power to direct
the receipt of dividends from, or the proceeds from the sale of, such
securities, a statement to that effect should be included in response to this
item and, if such interest relates to more than five percent of the class, such
person should be identified. A listing of the shareholders of an investment
company registered under the Investment Company Act of 1940 or the beneficiaries
of employee benefit plan, pension fund or endowment fund is not required.
NOT APPLICABLE
Item 7. Identification and Classification of the Subsidiary Which Acquired the
Security Being Reported on by the Parent Holding Company
If a parent holding company has filed this schedule pursuant to Rule 13d-1(b)
(1)(ii)(G), so indicate under Item 3(g) and attach an exhibit stating the
identity and the Item 3 classification of the relevant subsidiary.
If a parent holding company has filed this schedule pursuant to Rule 13d-1(c)
or Rule 13d-1-(c), attach an exhibit stating the identification of the relevant
subsidiary.
NOT APPLICABLE
Item 8. Identification and Classification of Members of the Group
If a group has filed this schedule pursuant to Rule 13d-1(b)(ii)(H), so indicate
under Item 3(h) and attach an exhibit stating the identity and Item 3
classification of each member of the group. If a group has filed this schedule
pursuant to Rule 13d-1(c)), attach an exhibit stating the identity of each
member of the group.
NOT APPLICABLE
Item 9. Notice of Dissolution of Group
Notice of dissolution of a group may be furnished as an exhibit stating the date
of the dissolution and that all further filings with respect to transactions in
the security reported on will be filed, if required, by members of the group, in
their individual capacity. See Item 5.
NOT APPLICABLE
Item 10. Certifications
The following certification shall be included if the statement is filed pursuant
to Rule 13d-1(b):
"By signing below I certify that, to the best of my knowledge and belief,
the securities referred to above were acquired and are held in the
ordinary course of business and were not acquired and are not held for
the purpose of or with the effect of changing or influencing the control
of the issuer of the securities and were not acquired and are not held in
connection with or as a participant in any transaction having that
purpose or effect."
NOT APPLICABLE
<PAGE>
Signature.
After reasonable inquiry and to the best of my knowledge and belief, I certify
that the information set forth in this statement is true, complete and correct.
February 2, 2000
---------------------------------
(Date)
/s/Allen Bain
---------------------------------
(Signature)
Allen Bain
---------------------------------
(Name/Title)
The original statement shall be signed by each person on whose behalf the
statement is filed or his authorized representative. If the statement is signed
on behalf of a person by his authorized representative (other than an executive
officer or general partner of the filing person), evidence of the
representative's authority to sign on behalf of such person shall be filed with
the statement, provided, however, that a power of attorney for this purpose
which is already on file with the Commission may be incorporated by reference.
The name and any title of each person who signs the statement shall be typed or
printed beneath his signature.
Note: Six copies of this statement, including all exhibits, should be filed with
the Commission
Attention: Intentional misstatements or omissions of fact constitute Federal
criminal violations (see 18 U.S.C. 1001).
--------------
<PAGE>
